Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.

Item
http://www.wikidata.org/entity/Q36919753
Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab.Food allergy: immune mechanisms, diagnosis and immunotherapyIgE-Related Chronic Diseases and Anti-IgE-Based Treatments.From IgE to Omalizumab.Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.Thermal sensitivity and flexibility of the Cε3 domains in immunoglobulin E.Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.Overlapping Effects of New Monoclonal Antibodies for Severe Asthma.Oral immunotherapy for food allergy.Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today.IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
P2860

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.

Item
http://www.wikidata.org/entity/Q36919753
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.
@en
type
label
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.
@en
prefLabel
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P698
P932
P356
P1433
P1476
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P698
P932